193 related articles for article (PubMed ID: 30018562)
1. A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury.
Zheng Q; Zhu JZ; Bao XY; Zhu PC; Tong Q; Huang YY; Zhang QH; Zhang KJ; Zheng GQ; Wang Y
Front Physiol; 2018; 9():795. PubMed ID: 30018562
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms.
Zheng Q; Bao XY; Zhu PC; Tong Q; Zheng GQ; Wang Y
Oxid Med Cell Longev; 2017; 2017():6313625. PubMed ID: 29430282
[TBL] [Abstract][Full Text] [Related]
3. Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms.
Zheng Q; Huang YY; Zhu PC; Tong Q; Bao XY; Zhang QH; Zheng GQ; Wang Y
Front Pharmacol; 2018; 9():729. PubMed ID: 30090062
[TBL] [Abstract][Full Text] [Related]
4. Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms.
Huang YY; Wu JM; Su T; Zhang SY; Lin XJ
Front Pharmacol; 2018; 9():1083. PubMed ID: 30327600
[TBL] [Abstract][Full Text] [Related]
5. Ginkgolide B for Myocardial Ischemia/Reperfusion Injury: A Preclinical Systematic Review and Meta-Analysis.
Zhu PC; Tong Q; Zhuang Z; Wang ZH; Deng LH; Zheng GQ; Wang Y
Front Physiol; 2019; 10():1292. PubMed ID: 31681006
[TBL] [Abstract][Full Text] [Related]
6. Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms.
Zhu PC; Shen J; Qian RY; Xu J; Liu C; Hu WM; Zhang Y; Lv LC
Front Pharmacol; 2023; 14():1165212. PubMed ID: 37261285
[No Abstract] [Full Text] [Related]
7. Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review.
Tong Q; Zhu PC; Zhuang Z; Deng LH; Wang ZH; Zeng H; Zheng GQ; Wang Y
Front Pharmacol; 2019; 10():1204. PubMed ID: 31680976
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis.
Zhuang Z; Wang ZH; Deng LH; Zheng Q; Zheng GQ; Wang Y
Front Pharmacol; 2019; 10():1388. PubMed ID: 31849654
[TBL] [Abstract][Full Text] [Related]
9. Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool.
Bao XY; Zheng Q; Tong Q; Zhu PC; Zhuang Z; Zheng GQ; Wang Y
Front Pharmacol; 2018; 9():1445. PubMed ID: 30618743
[No Abstract] [Full Text] [Related]
10. The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia-reperfusion injury by inhibiting the STING pathway.
Zhai P; Chen Q; Wang X; Ouyang X; Yang M; Dong Y; Li J; Li Y; Luo S; Liu Y; Cheng X; Zhu R; Hu D
Chin Med; 2024 Feb; 19(1):34. PubMed ID: 38419127
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis.
Wang H; Zhuang Z; Huang YY; Zhuang ZZ; Jin Y; Ye HY; Lin XJ; Zheng Q; Wang YL
Front Pharmacol; 2020; 11():988. PubMed ID: 32695006
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro.
Zhang WD; Chen H; Zhang C; Liu RH; Li HL; Chen HZ
Planta Med; 2006 Jan; 72(1):4-8. PubMed ID: 16450288
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of curcumin against myocardial I/R injury: A systematic review and meta-analysis of preclinical and clinical studies.
Li T; Jin J; Pu F; Bai Y; Chen Y; Li Y; Wang X
Front Pharmacol; 2023; 14():1111459. PubMed ID: 36969839
[No Abstract] [Full Text] [Related]
14. Clinical and Preclinical Systematic Review of Astragalus Membranaceus for Viral Myocarditis.
Zheng Q; Zhuang Z; Wang ZH; Deng LH; Jin WJ; Huang ZJ; Zheng GQ; Wang Y
Oxid Med Cell Longev; 2020; 2020():1560353. PubMed ID: 33204391
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury from Oxidative Stress by Regulating Succinate, Lysophospholipid Metabolism, and ROS Scavenging System.
Jiang M; Ni J; Cao Y; Xing X; Wu Q; Fan G
Oxid Med Cell Longev; 2019; 2019():9137654. PubMed ID: 31341538
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms.
Wang HL; Zhou QH; Xu MB; Zhou XL; Zheng GQ
Oxid Med Cell Longev; 2017; 2017():8424326. PubMed ID: 28303172
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
[TBL] [Abstract][Full Text] [Related]
18. Extracts from Astragalus membranaceus limit myocardial cell death and improve cardiac function in a rat model of myocardial ischemia.
Ma X; Zhang K; Li H; Han S; Ma Z; Tu P
J Ethnopharmacol; 2013 Oct; 149(3):720-8. PubMed ID: 23968862
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis.
Chen C; Lin Q; Zhu XY; Xia J; Mao T; Chi T; Wan J; Lu JJ; Li Y; Cui J; Liu J; Cui XY; Zhang J; Zhou K; Li D
Front Cardiovasc Med; 2021; 8():646306. PubMed ID: 34124190
[No Abstract] [Full Text] [Related]
20. Astragaloside IV alleviates ischemia reperfusion-induced apoptosis by inhibiting the activation of key factors in death receptor pathway and mitochondrial pathway.
Yin F; Zhou H; Fang Y; Li C; He Y; Yu L; Wan H; Yang J
J Ethnopharmacol; 2020 Feb; 248():112319. PubMed ID: 31639488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
